Adverse effects and drug interactions relating to use of St. John's wort

Canadian Pharmacists Journal

Volumn 139, Issue 1, 2006, Pages 30-33

  Laeeque, Hina ^a   Charrois, Theresa L ^a   Vohra, Sunita ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CARE Program   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERICUM PERFORATUM EXTRACT; NATURAL PRODUCT; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; HERBACEOUS AGENT;

ARTICLE; CANADA; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FATIGUE; HEADACHE; HUMAN; HYPERICUM PERFORATUM; NAUSEA; PATIENT CARE; PHOTOSENSITIVITY; RESTLESSNESS; SEASONAL AFFECTIVE DISORDER; SIDE EFFECT; TRADITIONAL MEDICINE; WELLBEING; XEROSTOMIA; ALTERNATIVE MEDICINE; HIGH RISK PATIENT; PRESCRIPTION; RISK BENEFIT ANALYSIS; SELF CARE; UNSPECIFIED SIDE EFFECT;

EID: 33645022476     PISSN: 17151635     EISSN: None     Source Type: Journal    
DOI: 10.1177/171516350613900107     Document Type: Article

References (16)

1. Volz HP. Controlled clinical trials of hypericum extracts in depressed patients - an overview. Pharmacopsychiatry 1997;30(Suppl 2):72-6.
2. National Centre for Complementary and Alternative Medicine. St. John's wort and the treatment of depression. March 2004. Available: http://nccam.nih.gov/health/stjohnswort/sjw.pdf (accessed November 2005).
3. Linde K, Mulrow CD. St. John's wort for depression. Cochrane Database Syst Rev 2000;(2):CD000448.
4. Linde K, Ramirez G, Mulrow CD, et al. St. John's wort for depression - an overview and meta-analysis of randomized clinical trials. BMJ 1996;313:253-8.
5. Hammerness P, Basch E, Ulbricht C, et al. St. John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychometrics 2003;44:271-82.
6. Health Canada. Food and Drug Regulations. Available: www.hc-sc.gc.ca/fn- an/legislation/acts-lois/fdr-rad/index_e.html (accessed November 2005).
7. Health Canada. St. John's wort monograph. January 2004. Available: www.hcsc. gc.ca/dhp-mps/prodnatur/applications/licen-prod/monograph/mono_ stjohnswort-millepertuis_e.html (accessed November 2005).
8. Natural Standard Monograph. St. John's wort. Natural Standard 2004. Available: www.naturalstandard.com (accessed November 2005).
9. Ernst E, Rand JI, Barnes J, Stevinson C. Adverse effects profile of the herbal antidepressant St. John's wort. Eur J Clin Pharmacol 1998;54:589-94.
10. Boon H, Smith M. The complete natural medicine guide to the 50 most common medicinal herbs. Toronto: The Institute of Naturopathic Education and Research; 2004.
11. Murphy PA, Kern SE, Stanczyk FZ, Westhoff CL. Interactions of St. John's wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Contraception 2005;71:402-8.
12. Izzo AA. Herb-drug interactions: an overview of the clinical evidence. Fundam Clin Pharmacol 2005;19:1-16.
13. Singh YN. Potential for interaction of kava and St. John's wort with drugs. J Ethnopharmacol 2005;100:108-13.
14. Brazier NC, Levine MAH. Drug-herb interaction among commonly used conventional medicines: a compendium for health-care professionals. Am J Ther 2003;10:163-9.
15. Yue QY, Bergquist C, Gerden B. Safety of St. John's wort (Hypericum perforatum). Lancet 2000;355:576-7.
16. Lee A, Minhas R, Matsuda N, Lam M, Ito S. The safety of St. John's wort (Hypericum perforatum) during breastfeeding. J Clin Psychiatry 2003;64:966-8.